```html

Jaundiced Eyes in Newborns

What is Jaundiced eyes in newborns?

Jaundice in newborns is a condition in which the skin and the whites of the eyes (sclera) develop a yellow‑orange tint. The discoloration occurs because of excess bilirubin—a yellow pigment produced when red blood cells break down. In a newborn, the liver may not yet be mature enough to process bilirubin efficiently, leading to a temporary buildup in the bloodstream.

When the excess bilirubin circulates, it stains tissues that contain many blood vessels, most notably the skin and the conjunctiva (the thin membrane that covers the white part of the eye). The term “jaundiced eyes” specifically refers to the yellowing of the sclera, which is often one of the first visible signs that a baby has elevated bilirubin levels.

Most cases of newborn jaundice are benign and resolve with simple care, but very high bilirubin levels can cross the blood‑brain barrier and cause permanent neurological damage (kernicterus). Recognizing jaundiced eyes early and seeking appropriate care is essential.

Common Causes

While mild jaundice is common in the first week of life, several underlying conditions can increase the risk of significant bilirubin accumulation. Below are the most frequent causes of jaundiced eyes in newborns:

• Physiologic newborn jaundice – Normal immaturity of the liver enzymes leads to temporary bilirubin build‑up, usually peaking between days 2–5.
• Breast‑milk jaundice – Occurs after the first week in breast‑fed infants; certain substances in breast milk interfere with bilirubin processing.
• Breast‑feeding failure jaundice – Inadequate milk intake leads to dehydration and reduced bilirubin elimination.
• Hemolytic disease of the newborn (HDN) – Maternal antibodies (e.g., Rh or ABO incompatibility) destroy fetal red cells, markedly raising bilirubin.
• Blood group incompatibility (ABO, Rh) – Similar to HDN, but may be milder; still a common trigger for early‑onset jaundice.
• G6PD deficiency – An inherited enzyme defect that makes red cells more fragile, leading to rapid hemolysis.
• Congenital infections (TORCH) – Infections such as cytomegalovirus, rubella, toxoplasmosis, or syphilis can impair liver function.
• Metabolic disorders – Conditions like hypothyroidism, galactosemia, or Crigler‑Najjar syndrome impair bilirubin conjugation.
• Birth‑related trauma – Bruising or hematoma from a difficult delivery releases extra red blood cells.
• Medications – Certain drugs given to the mother (e.g., sulfonamides) or to the infant can increase bilirubin levels.

Identifying the underlying cause guides treatment and helps prevent recurrence in later pregnancies.

Associated Symptoms

Jaundiced eyes rarely appear in isolation. Look for the following accompanying signs, which can provide clues about the severity and cause:

• Yellowing of the skin, beginning on the face and progressing down the torso.
• Lethargy or poor feeding – the baby may be unusually sleepy or refuse feeds.
• Dark urine (bilirubin‑colored) and pale (clay‑colored) stools.
• High‑pitch crying or irritability.
• Rapid weight loss or failure to gain weight.
• Presence of hemolysis: pallor, dark (tea‑colored) blood in stool, or a rapid drop in hemoglobin.
• Signs of infection: fever, temperature instability, or a rash.
• Rarely, neurological changes such as high‑pitched cry, arching of the back (opisthotonus), or seizures (suggesting kernicterus).

When to See a Doctor

Newborn jaundice can progress quickly. Contact your pediatrician or seek urgent care if you notice any of the following:

• The yellow color appears within the first 24 hours of life.
• Jaundice spreads to the abdomen or legs, or the sclera become markedly yellow.
• Feeding difficulties, vomiting, or a drop in urine output.
• Baby is unusually sleepy, difficult to awaken, or has a high‑pitched cry.
• Parent or family history of blood‑type incompatibility, G6PD deficiency, or liver disease.
• Any sign of fever (>100.4 °F / 38 °C) or poor temperature regulation.
• Premature infants (<37 weeks gestation) with any visible jaundice.

Early evaluation is especially important for infants born pre‑term, low birth weight, or with known risk factors.

Diagnosis

Healthcare providers use a combination of visual assessment, laboratory testing, and sometimes imaging to evaluate jaundiced eyes.

1. Physical Examination

• Inspection of the sclera, skin, and mucous membranes.
• Assessment of hydration status, weight trends, and feeding patterns.

2. Bilirubin Measurement

• Transcutaneous bilirubinometer – A painless skin sensor that provides an estimate.
• Serum total bilirubin (TSB) – Blood draw for precise measurement; distinguishes direct (conjugated) vs indirect (unconjugated) bilirubin.

3. Additional Laboratory Tests (if indicated)

• Complete blood count (CBC) and reticulocyte count – to assess hemolysis.
• Blood type and Coombs test – to detect antibody‑mediated hemolysis.
• G6PD assay, thyroid function tests, or metabolic screens – based on clinical suspicion.
• Liver function panel – especially if conjugated hyperbilirubinemia is suspected.

4. Imaging (rarely needed)

• Abdominal ultrasound to evaluate biliary obstruction if conjugated bilirubin is high.

Guidelines from the American Academy of Pediatrics (AAP) and the National Institute for Health and Care Excellence (NICE) provide bilirubin‑threshold charts based on age in hours, gestational age, and risk factors to decide treatment urgency.

Treatment Options

The goal of therapy is to lower bilirubin levels safely and prevent neurotoxicity.

Phototherapy

• Standard first‑line treatment for most cases of significant unconjugated hyperbilirubinemia.
• Blue‑green light (460‑490 nm) converts bilirubin into water‑soluble isomers that are excreted without liver conjugation.
• Types:
  • Conventional overhead lamps.
  • LED pads or blankets that can be used at home under physician guidance.
• Typical duration: 12–48 hours, with bilirubin checked frequently.

Exchange Transfusion

• Reserved for severe cases where bilirubin is near or exceeds neurotoxic thresholds despite phototherapy.
• Blood is removed and replaced with donor blood to rapidly lower bilirubin and treat hemolysis.
• Performed in a neonatal intensive care unit (NICU) by experienced staff.

Intravenous Immunoglobulin (IVIG)

• Used in antibody‑mediated hemolysis (e.g., Rh incompatibility) to reduce ongoing red‑cell destruction.
• May decrease the need for exchange transfusion.

Supportive Measures

• Frequent feeding – 8–12 times/day for breast‑fed infants; ensures adequate hydration and stool output, promoting bilirubin excretion.
• Supplemental formula – If breast‑feeding failure is suspected, temporary supplementation can correct caloric deficit.
• Sunlight exposure – Limited, indirect sunlight for short periods (10–15 minutes) may help reduce bilirubin, but should not replace medical treatment.

Treatment of Underlying Causes

• Maternal‑blood‑type incompatibility → Rh immunoglobulin (Rho(D) immune globulin) for future pregnancies.
• G6PD deficiency → Avoid oxidative stressors; treat hemolysis with supportive care.
• Metabolic disorders → Specific dietary or enzyme replacement therapy (e.g., lactose‑free formula for galactosemia).

Prevention Tips

While some jaundice is unavoidable, several strategies can lower the risk of severe jaundiced eyes:

• Early and frequent feeding – Initiate breastfeeding within the first hour after birth and aim for at least 8–12 feeds per 24 hours.
• Monitor weight – Newborns should regain birth weight by day 10; a decline signals inadequate intake.
• Screen for blood‑type incompatibility – Prenatal testing for maternal and paternal ABO/Rh status helps anticipate hemolytic risk.
• Vitamin K and hepatitis B prophylaxis – Standard newborn vaccines protect liver health.
• Educate parents about the normal timeline of physiologic jaundice (usually peaks day 3‑5) and warning signs.
• Delay elective deliveries when possible – Full‑term births (≥39 weeks) have more mature liver function.
• Avoid unnecessary medications in the mother that can increase neonatal bilirubin (e.g., certain sulfonamides).

Emergency Warning Signs

Key Take‑aways

• Jaundiced eyes are a visual cue of elevated bilirubin, most often benign but potentially dangerous.
• Common causes include physiologic jaundice, breastfeeding issues, and hemolytic disease.
• Prompt evaluation with transcutaneous or serum bilirubin measurement guides treatment.
• Phototherapy is the cornerstone of care; severe cases may need exchange transfusion.
• Early feeding, proper weight monitoring, and parental education are the best preventive measures.
• Seek immediate medical help for rapid progression, poor feeding, lethargy, fever, or neurologic changes.

---

References:

1. Mayo Clinic. Newborn jaundice. https://www.mayoclinic.org/diseases-conditions/jaundice-in-newborns/diagnosis-treatment/drc-20374312 (accessed June 2026).
2. American Academy of Pediatrics. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;149(5):e2021054435.
3. World Health Organization. Guidelines for the management of newborn health. 2023.
4. National Institute of Child Health and Human Development. Jaundice in newborns. https://www.nichd.nih.gov (accessed June 2026).
5. Cleveland Clinic. Neonatal Jaundice: Causes, Symptoms, and Treatment. https://my.clevelandclinic.org (accessed June 2026).

```